ABL 1

Definition & Etymology

ABL1 (Abelson Tyrosine Kinase 1) is a proto-oncogene located on chromosome 9 that encodes a non-receptor tyrosine kinase protein. This protein plays a crucial role in various cellular processes, including cell proliferation, differentiation, adhesion, and stress response. It functions as a key regulator in multiple signal transduction pathways. (The name derives from the Abelson murine leukemia virus, where the homologous oncogene, v-Abl, was first discovered).

Clinical Significance

The primary clinical significance of ABL1 lies in its involvement in carcinogenesis, particularly in hematologic malignancies. The hallmark event is a reciprocal translocation between chromosome 9 and 22, t(9;22)(q34;q11), which creates the Philadelphia chromosome. This translocation results in the fusion of the ABL1 gene with the BCR (Breakpoint Cluster Region) gene, forming the pathognomonic BCR-ABL1 fusion gene. The resulting fusion protein has constitutively active (unregulated) tyrosine kinase activity, which drives the uncontrolled cell growth characteristic of certain leukemias. This discovery was pivotal in developing targeted cancer therapies.

Related Conditions

The presence of the BCR-ABL1 fusion gene is the defining molecular abnormality in nearly all cases of Chronic Myeloid Leukemia (CML). It is also found in approximately 25% of adult cases and 2-5% of pediatric cases of Acute Lymphoblastic Leukemia (ALL), referred to as Philadelphia chromosome-positive ALL (Ph+ ALL). The detection of this fusion gene is critical for diagnosis, prognosis, and guiding treatment with specific drugs known as Tyrosine Kinase Inhibitors (TKIs), such as imatinib.

Key Takeaways

• ABL1 is a proto-oncogene encoding a tyrosine kinase protein essential for normal cell signaling.
• Its translocation with the BCR gene creates the BCR-ABL1 fusion gene (Philadelphia chromosome), a key driver of cancer.
• This genetic abnormality is the diagnostic and therapeutic cornerstone of Chronic Myeloid Leukemia (CML) and a subset of Acute Lymphoblastic Leukemia (ALL).

Note: This content is for informational purposes only and does not substitute for professional medical advice. Always consult your doctor for diagnosis and treatment.